Antibe Therapeutics Inc(Pre-Merger) ATBPF

RE:RE:RE:RE:Stock price

[themagicbox]

Very interesting points and I agree with many. 

I am more conservative in whether they'll be grant *extended* protection. Which is why I am suspecting they are going after fresh IP.

I nailed the prediction that they would go the acute route. So in that same vain I think negotiations is all well and good for a buyout but I think they will likely end up partnering up for ph3 once they go through the soft/hard tissue ph2 trials.

I am VERY confident they will go through it with negligable issues. Then find the quickest way to get this drug to market, off label use for chronic pain will skyrocket, and any liver enzyme elevation will be managed by your PHC provider. This is SOOOOO common in the medical field.

To all the FUD trolls, the sad truth in medicine is that ALL medications, in the medium-long term, negatively affects the liver, especially in the NSAIDs and antipyretics class of medications. This is a common issue.  Despite the black box label for liver issues with anti pyretics, theyre still on the market but they are all managed.

Anitbes drug HAS solved the ulceration problem, this has been implicated in many other issues such anemia, IBS/IBD, and many many others. Now its all about passing through the hoops.

TL;DR to avoid dilution they need enough money to make it to ph3 and then money will come from partnership.